C
CRBU
Caribou Biosciences, Inc.
1.440
-0.100-6.49%After Hours: 1.460 +0.020 +1.39%19:30 09/09 EDT
OPEN/PREV CLOSE1.540/1.540
TODAY RANGE1.440-1.540
VOL1.77M
MARKET CAP154.38M
52 WEEK RANGE1.380-3.535
AVG VOL (3M)1.69M
% TURNOVER1.63%
TURNOVER--
P/E (TTM)-1.3362
% RANGE6.49%
EPS(TTM)-1.0777
P/E(FORWARD)-1.3446
P/B1.556
BVPS0.9255
DIVIDEND--
P/S12.28
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP141.69M
SHARES OUTSTANDING107.21M
NEXT EARNINGS11/09-11/22
FREE FLOAT98.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·08/26 15:17
Here's Why You Should Retain IQVIA Stock in Your Portfolio Now
TipRanks·08/17 10:29
RBC Capital Keeps Their Buy Rating on Caribou Biosciences (CRBU)
TipRanks·08/16 14:03
Caribou Biosciences reports Q2 EPS (24c), consensus (31c)
TipRanks·08/16 13:45
Caribou Biosciences price target lowered to $5 from $6 at BofA
Dow Jones·08/14 18:35
Caribou Biosciences Price Target Cut to $5.00/Share From $6.00 by B of A Securities
Dow Jones·08/14 18:35
Caribou Biosciences Is Maintained at Buy by B of A Securities
Seeking Alpha·08/14 17:18
Adicet Bio: A Cheap Gamma Delta T-Cell Play
NASDAQ·08/13 22:05
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates
Dow Jones·08/13 20:05
Press Release: Caribou Biosciences Reports Second -2-
Simply Wall St·08/06 17:05
Spotlight On Promising Penny Stocks For August 2026
TipRanks·07/06 18:35
Citizens biotech analyst holds an analyst/industry conference call
TipRanks·07/02 19:25
Citizens biotech analysts hold an analyst/industry conference call
Same Industry
Name/Symbol
Change%
Price